TIVORBEX Drug Patent Profile

When do Tivorbex patents expire, and when can generic versions of Tivorbex launch?

Tivorbex is a drug marketed by Genus and is included in one NDA. There are three patents protecting this drug.

This drug has thirty-seven patent family members in twenty-one countries.

The generic ingredient in TIVORBEX is indomethacin. There are fifteen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the indomethacin profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Tivorbex

A generic version of TIVORBEX was approved as indomethacin by CHARTWELL MOLECULES on March 5^th, 1986.

Summary for TIVORBEX

International Patents:	37
US Patents:	3
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	163
Clinical Trials:	2
Patent Applications:	5,989
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for TIVORBEX
What excipients (inactive ingredients) are in TIVORBEX?	TIVORBEX excipients list
DailyMed Link:	TIVORBEX at DailyMed

See drug prices for TIVORBEX

Recent Clinical Trials for TIVORBEX

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
National University, Singapore	Phase 2
Sen-Jam Pharmaceutical	Phase 2
Iroko Pharmaceuticals, LLC	Phase 2

See all TIVORBEX clinical trials

US Patents and Regulatory Information for TIVORBEX

TIVORBEX is protected by three US patents.

Patents protecting TIVORBEX

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Genus	TIVORBEX	indomethacin	CAPSULE;ORAL	204768-001	Feb 24, 2014		DISCN	Yes	No
Genus	TIVORBEX	indomethacin	CAPSULE;ORAL	204768-002	Feb 24, 2014		DISCN	Yes	No
Genus	TIVORBEX	indomethacin	CAPSULE;ORAL	204768-001	Feb 24, 2014		DISCN	Yes	No			Y
Genus	TIVORBEX	indomethacin	CAPSULE;ORAL	204768-001	Feb 24, 2014		DISCN	Yes	No			Y
Genus	TIVORBEX	indomethacin	CAPSULE;ORAL	204768-002	Feb 24, 2014		DISCN	Yes	No			Y

International Patents for TIVORBEX

See the table below for patents covering TIVORBEX around the world.

Country	Patent Number	Title	Estimated Expiration
Australia	2016200397	A Novel Formulation of Indomethacin
Eurasian Patent Organization	201171286	НОВАЯ ТЕХНОЛОГИЯ ИЗГОТОВЛЕНИЯ ИНДОМЕТАЦИНА
China	103932988	Novel Formulation of Indomethacin
South Korea	20140077945	A NOVEL FORMULATION OF INDOMETHACIN
Japan	6239709